59 related articles for article (PubMed ID: 24026983)
21. Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy.
Roscoe JA; Heckler CE; Morrow GR; Mohile SG; Dakhil SR; Wade JL; Kuebler JP
J Clin Oncol; 2012 Sep; 30(27):3389-95. PubMed ID: 22915657
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients' quality of life.
Fernández-Ortega P; Caloto MT; Chirveches E; Marquilles R; Francisco JS; Quesada A; Suárez C; Zorrilla I; Gómez J; Zabaleta P; Nocea G; Llombart-Cussac A
Support Care Cancer; 2012 Dec; 20(12):3141-8. PubMed ID: 22460057
[TBL] [Abstract][Full Text] [Related]
23. The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER).
Aapro M; Molassiotis A; Dicato M; Peláez I; Rodríguez-Lescure Á; Pastorelli D; Ma L; Burke T; Gu A; Gascon P; Roila F;
Ann Oncol; 2012 Aug; 23(8):1986-1992. PubMed ID: 22396444
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of computerized physician order entry in an electronic health record after implementation in an outpatient oncology setting.
Harshberger CA; Harper AJ; Carro GW; Spath WE; Hui WC; Lawton JM; Brockstein BE
J Oncol Pract; 2011 Jul; 7(4):233-7. PubMed ID: 22043187
[TBL] [Abstract][Full Text] [Related]
25. Computerized provider order entry in pediatric oncology: design, implementation, and outcomes.
Chen AR; Lehmann CU
J Oncol Pract; 2011 Jul; 7(4):218-22. PubMed ID: 22043183
[TBL] [Abstract][Full Text] [Related]
26. Electronic Chemotherapy Order Entry: A Major Cancer Center's Implementation.
Sklarin NT; Granovsky S; O'Reilly EM; Zelenetz AD
J Oncol Pract; 2011 Jul; 7(4):213-8. PubMed ID: 22043182
[TBL] [Abstract][Full Text] [Related]
27. Palonosetron plus 1-day dexamethasone for the prevention of nausea and vomiting due to moderately emetogenic chemotherapy: effect of established risk factors on treatment outcome in a phase III trial.
Celio L; Denaro A; Agustoni F; Bajetta E
J Support Oncol; 2012; 10(2):65-71. PubMed ID: 22005217
[TBL] [Abstract][Full Text] [Related]
28. Antiemetics: American Society of Clinical Oncology clinical practice guideline update.
Basch E; Prestrud AA; Hesketh PJ; Kris MG; Feyer PC; Somerfield MR; Chesney M; Clark-Snow RA; Flaherty AM; Freundlich B; Morrow G; Rao KV; Schwartz RN; Lyman GH;
J Clin Oncol; 2011 Nov; 29(31):4189-98. PubMed ID: 21947834
[TBL] [Abstract][Full Text] [Related]
29. Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting.
Burmeister H; Aebi S; Studer C; Fey MF; Gautschi O
Support Care Cancer; 2012 Jan; 20(1):141-7. PubMed ID: 21234609
[TBL] [Abstract][Full Text] [Related]
30. Use of antiemetics in the management of chemotherapy-related nausea and vomiting in current UK practice.
Molassiotis A; Brearley SG; Stamataki Z
Support Care Cancer; 2011 Jul; 19(7):949-56. PubMed ID: 20574666
[TBL] [Abstract][Full Text] [Related]
31. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.
Roila F; Herrstedt J; Aapro M; Gralla RJ; Einhorn LH; Ballatori E; Bria E; Clark-Snow RA; Espersen BT; Feyer P; Grunberg SM; Hesketh PJ; Jordan K; Kris MG; Maranzano E; Molassiotis A; Morrow G; Olver I; Rapoport BL; Rittenberg C; Saito M; Tonato M; Warr D;
Ann Oncol; 2010 May; 21 Suppl 5():v232-43. PubMed ID: 20555089
[No Abstract] [Full Text] [Related]
32. Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis.
Botrel TE; Clark OA; Clark L; Paladini L; Faleiros E; Pegoretti B
Support Care Cancer; 2011 Jun; 19(6):823-32. PubMed ID: 20495832
[TBL] [Abstract][Full Text] [Related]
33. Obstacles to the implementation of antiemetic guidelines.
Grunberg SM
J Natl Compr Canc Netw; 2009 May; 7(5):601-5. PubMed ID: 19460283
[TBL] [Abstract][Full Text] [Related]
34. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.
Saito M; Aogi K; Sekine I; Yoshizawa H; Yanagita Y; Sakai H; Inoue K; Kitagawa C; Ogura T; Mitsuhashi S
Lancet Oncol; 2009 Feb; 10(2):115-24. PubMed ID: 19135415
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy-induced nausea and vomiting in routine practice: a European perspective.
Glaus A; Knipping C; Morant R; Böhme C; Lebert B; Beldermann F; Glawogger B; Ortega PF; Hüsler A; Deuson R
Support Care Cancer; 2004 Oct; 12(10):708-15. PubMed ID: 15278682
[TBL] [Abstract][Full Text] [Related]
36. Cancer patients submitted to innovative chemotherapeutic agents of intermediate emetogenic potential: antiemetic prescriptions and incidence of emesis.
Tumori; 2004; 90(1):103-6. PubMed ID: 15143981
[TBL] [Abstract][Full Text] [Related]
37. Transferring scientific evidence to oncological practice: a trial on the impact of three different implementation strategies on antiemetic prescriptions.
Roila F
Support Care Cancer; 2004 Jun; 12(6):446-53. PubMed ID: 15045572
[TBL] [Abstract][Full Text] [Related]
38. Antiemetic prescription in Italian breast cancer patients submitted to adjuvant chemotherapy.
Drug Utilization Review Team in Oncology (DURTO)
Support Care Cancer; 2003 Dec; 11(12):785-9. PubMed ID: 14579136
[TBL] [Abstract][Full Text] [Related]
39. Improving the care of patients with regard to chemotherapy-induced nausea and emesis: the effect of feedback to clinicians on adherence to antiemetic prescribing guidelines.
Mertens WC; Higby DJ; Brown D; Parisi R; Fitzgerald J; Benjamin EM; Lindenauer PK
J Clin Oncol; 2003 Apr; 21(7):1373-8. PubMed ID: 12663729
[TBL] [Abstract][Full Text] [Related]
40. Is delayed chemotherapy-induced emesis well managed in oncological clinical practice? An observational study.
Fabi A; Barduagni M; Lauro S; Portalone L; Mauri M; Marinis F; Narduzzi C; Tonini G; Giampaolo M; Pacetti U; Paoloni F; Cognetti F
Support Care Cancer; 2003 Mar; 11(3):156-61. PubMed ID: 12618925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
